CELUCelularity Incvs its industry peers
A metric-by-metric comparison of Celularity Inc against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CELUThis | $27M#4 | — | — | 1.0x#3 | -51.0%#4 | -58.4%#3 | -230.9%#3 | — | -260.7%#3 | — | -56.4%#2 | — |
| LITS | $30M#1 | — | 0.7x#4 | — | -100.0%#5 | -346.2%#6 | — | -170.9%#5 | — | — | — | — |
| FLNA | $29M#2 | — | 0.4x#2 | 0.7x#2 | 277.6%#1 | -273.7%#5 | -232.0%#4 | -133.5%#4 | — | — | -81.4%#3 | — |
| AARD | $28M#3 | — | 0.4x#1 | — | — | -179.7%#4 | — | -77.0%#3 | — | — | — | — |
| AYTU | $21M#5 | — | 0.6x#3 | 0.4x#1 | -13.3%#3 | -5.1%#2 | -14.4%#1 | -40.5%#2 | -43.8%#2 | 4#2 | — | — |
| TXMD | $21M#6 | — | 0.8x#5 | 6.9x#4 | 71.6%#2 | 73.9%#1 | -145.3%#2 | -2.1%#1 | -3.8%#1 | 5#1 | 50.0%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice